5-[(2-Hydroxyethyl)Amino]-o-Cresol | CAS:55302-96-0

We serve 5-[(2-Hydroxyethyl)Amino]-o-Cresol CAS:55302-96-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-[(2-Hydroxyethyl)Amino]-o-Cresol

Chemical Name:5-[(2-Hydroxyethyl)Amino]-o-Cresol
CAS.NO:55302-96-0
Synonyms:5-(2-hydroxyethylamino)-2-methylphenol;
Molecular Formula:C9H13NO2
Molecular Weight:167.20500
 
Physical and Chemical Properties:
Density:1.215;
Melting point:90-92oC;
Boiling point:366oC;
Flash point:181.4oC;
Index of Refraction:1.626;
 
Specification:
Appearance:Beige crystalline powder
Purity(HPLC):≥99.0%
Loss on drying:≤0.5%
Fe content:≤100ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate



Contact us for information like 5-[(2-Hydroxyethyl)Amino]-o-Cresol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(2-hydroxyethylamino)-2-methylphenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-[(2-Hydroxyethyl)Amino]-o-Cresol Use and application,5-[(2-Hydroxyethyl)Amino]-o-Cresol technical grade,usp/ep/jp grade.


Related News: With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.2-aminoguanidine carbonic acid manufacturer With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.5-(Methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid supplier “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.butane-2,3-dione vendor “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.“Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.